6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04070495 (ClinicalTrials.gov)	August 27, 2019	26/8/2019	A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin	A Drug Interaction Study of KW-6356 and Clarithromycinor Rifampicin (A Drug Interaction Study With a ...	Parkinson's Disease	Drug: KW-6356;Drug: Clarithromycin;Drug: Rifampicin	Kyowa Kirin Co., Ltd.	NULL	Completed	20 Years	44 Years	Male	20	Phase 1	Japan
2	NCT03440112 (ClinicalTrials.gov)	January 29, 2018	26/1/2018	Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm	Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson	Parkinson Disease	Drug: Clarithromycin (Not used as of 4/2020);Drug: Placebo (Not used as of 4/2020);Drug: Transdermal ...	Nicolaas Bohnen, MD, PhD	National Institute of Neurological Disorders and Stroke (NINDS)	Recruiting	50 Years	N/A	All	30	Phase 1/Phase 2	United States

First Previous1Next Last